Locally Advanced Stage III (C) Prostate Cancer

Genomic Test May Help Guide Prostate Cancer Treatment (05-13-2013)

A new genetic test—the Oncotype DX® Prostate Cancer Test—measures the aggressiveness of prostate cancer and may help scores of men choose between immediate treatment or active surveillance. The test was shown to strongly predict aggressiveness of... Continue Reading

Early Radiation Improves Prostate Cancer Survival (03-7-2013)

Immediate radiation therapy after radical prostatectomy resulted in a 50 percent increase in long-term biochemical progression-free survival (bNED) in men with locally advanced prostate cancer, according to the results of a study presented at the Genitourinary... Continue Reading

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (01-28-2013)

Proton therapy does not reduce toxicity compared with intensity-modulated radiation therapy (IMRT) in men with prostate cancer, according to the results of a study published in the Journal of the National Cancer Institute. Prostate cancer is the most... Continue Reading

Viagra Improves Sexual Function after Radiation for Prostate Cancer (11-15-2012)

Viagra® (sildenafil citrate) administered before, during, and after radiation therapy improved overall sexual function in prostate cancer patients, according to the results of a study presented at the 54th annual meeting of the American Society for... Continue Reading

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (09-18-2012)

Hormone therapy given intermittently (with breaks) has proven to be as effective as hormone therapy given continuously in asymptomatic men with rising PSA levels after prostate cancer treatment, according to the results of a study published in the New... Continue Reading

Men with Cardiovascular Disease More Likely to Regret Prostate Cancer Treatment (07-10-2012)

Prostate cancer patients with cardiovascular disease were 52 percent more likely to regret their treatment choices than their counterparts, according to a study published in BJUI International. Prostate cancer is the most commonly diagnosed cancer (other... Continue Reading

Side Effects of Prostate Cancer Treatment Persist Long-Term (07-5-2012)

Men who are treated for prostate cancer may continue to suffer from side effects 10 years after treatment, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, more than 192,000 men are diagnosed... Continue Reading

Neoadjuvant Zytiga Plus Hormonal Therapy Can Eliminate Tumor in Some Men with High-Risk Prostate Cancer (06-7-2012)

Six months of neoadjuvant treatment with the targeted agent Zytiga® (abiraterone) plus hormonal therapy eliminated or nearly eliminated tumors in one-third of men with localized high-risk prostate cancer, according to the results of a study presented... Continue Reading

Less Invasive Prostate Removal Safer than Traditional Surgery (04-24-2012)

Minimally-invasive radical prostatectomy (MIRP) proves safer than traditional open surgery—resulting in fewer post-surgical complications, fewer blood transfusions, and shorter hospital stays, according to the results of a study published in European... Continue Reading

Adding Radiation Therapy To Hormone Therapy Benefits Men with Locally Advanced Prostate Cancer (11-14-2011)

For men with locally advanced or high-risk prostate cancer, treatment with a combination of radiation therapy and hormone therapy appears to be more effective than hormone therapy alone. These results were published in The Lancet. Locally advanced prostate... Continue Reading

« Previous PageNext Page »